The global metastatic melanoma market is poised for significant growth and positive outlook in the forecast period of 2021 to 2029. With the market valued at $6.5 billion in 2021 and projected to reach $16.09 billion by 2029, the industry is expected to experience a robust CAGR during this period. Several factors are contributing to this growth, including an increasing incidence of melanoma...